hit counter

Trintellix (Vortioxetine) & Weight Gain or Weight Loss?

Trintellix (Vortioxetine hydrobromide), formerly sold under the name Brintellix, is an antidepressant that was jointly developed by the pharmaceutical companies Lundbeck and Takeda.  In 2013, Trintellix received FDA approval for the treatment of major depressive disorder in the United States.  Trintellix is classified as a “serotonin modulator and stimulator” in that it functions as an …

Read more

Brintellix (Vortioxetine) Withdrawal Symptoms + How Long They Last

Brintellix (Vortioxetine) is considered an atypical antidepressant that was co-developed by pharmaceutical companies Lundbeck and Takeda. Most consider Brintellix to be a new antidepressant as of 2014 due to the fact that it was approved by the FDA in September of 2013. In clinical trials, it proved to demonstrate substantial efficacy for the treatment of …

Read more

Brintellix (Vortioxetine) Side Effects: List Of Possibilities

Brintellix (Vortioxetine) is a drug that was approved by the FDA in 2013 to treat major depression. It is regarded as an atypical antidepressant, meaning that it’s mechanisms of action are unique from other classifications. As the marketing and promotion of this newer (2013) antidepressant continues, the number of people experimenting with it for their …

Read more

Atypical Antidepressants: List Of Examples

Atypical antidepressants are unique from other classes of antidepressants based on pharmacological properties. These days, the most common antidepressants fit into one of a few categories: SSRIs/SNRIs, TCAs, and MAOIs. Respectively these are: selective-serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclics (TCAs), and monoamine oxidase inhibitors (MAOIs). SSRIs and SNRIs are considered the …

Read more